Delcath (NASDAQ: DCTH) is a development-stage, specialty pharmaceutical and medical device company focused on oncology. Company is researching breakthroughs in regional chemotherapies with the goal of improving clinical outcomes and potentially reducing drug-related adverse events. At glance: Commercial stage company focused on oncology Proprietary CHEMOSAT delivery systems allow unique whole organ therapy for the liver …Read More